Movement Alert｜CANSINOBIO Intraday Rise 6.1% in Regular Trading, Third-Quarter Revenue and Profit Growth Support Sentiment

Market Focus10-28

On October 28, CANSINOBIO rose 6.1% in Regular Trading, trading at HK$29.18, with turnover of HK$85.06 million.

The move followed the company’s latest third-quarter results, which showed revenue of RMB882 million for the first nine months, up 27.40% year over year, and attributable net profit of RMB16.29 million, up 12.82%, helping support market sentiment.

Further details showed third-quarter revenue of RMB332 million, up 7.17% year over year. Non-recurring gains totaled RMB61.27 million in the first nine months, mainly including government grants of RMB23.60 million and fair-value and investment disposal gains of RMB27.40 million. R&D spending was RMB260 million, down 5.33% year over year, equivalent to 29.42% of revenue. The company also said the first batch of restricted stock vesting involved 811,320 shares, while impairment charges and deferred tax asset write-downs together affected net profit by RMB33.03 million.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment